Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

Clinical trial NCT03948724 · COMPLETED

Trial details

NCT number: NCT03948724
Sponsor: Institut Cancerologie de l'Ouest
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Therapeutic Patient Education Immune Checkpoint Inhibitors Melanoma Advanced Non-small Cell Lung Cancer Renal Cell Carcinoma Head and Neck Cancer Immune-related Adverse Event

Start date: 2019-12-11
Primary completion: 2023-08-04
Enrollment: 411

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.